Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients. [electronic resource]
Producer: 20140825Description: 1375-82 p. digitalISSN:- 2299-5684
- Administration, Oral
- Adult
- Aged
- Anticoagulants -- administration & dosage
- Aryl Hydrocarbon Hydroxylases -- genetics
- Blood Coagulation -- drug effects
- Chi-Square Distribution
- Cytochrome P-450 CYP2C9
- Drug Dosage Calculations
- Drug Monitoring
- Female
- Genotype
- Humans
- India
- International Normalized Ratio
- Logistic Models
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Pharmacogenetics
- Phenotype
- Polymorphism, Genetic
- Vitamin K Epoxide Reductases -- genetics
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.